PI
HAE icon

PineBridge Investments’s Haemonetics HAE Stock Holding History

PineBridge Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22,483
Closed -$1.76M – 765
2024
Q4 		$1.76M Buy
22,483
+6,727
+43% +$540K 0.01% 586
2024
Q3 		$1.27M Buy
+15,756
New +$1.27M 0.01% 615
2018
Q4 		– Sell
-470
Closed -$54K – 1091
2018
Q3 		$54K Sell
470
-33,149
-99% -$3.43M ﹤0.01% 965
2018
Q2 		$3.02M Sell
33,619
-5,490
-14% -$464K 0.07% 241
2018
Q1 		$2.86M Sell
39,109
-11,301
-22% -$775K 0.07% 247
2017
Q4 		$2.93M Buy
50,410
+9,343
+23% +$492K 0.08% 236
2017
Q3 		$1.84M Sell
41,067
-217
-0.5% -$9.02K 0.04% 323
2017
Q2 		$1.63M Sell
41,284
-1,268
-3% -$52.1K 0.04% 327
2017
Q1 		$1.73M Buy
42,552
+12,806
+43% +$500K 0.05% 336
2016
Q4 		$1.2M Buy
29,746
+23,223
+356% +$876K 0.04% 354
2016
Q3 		$237K Buy
6,523
+50
+0.8% +$1.72K 0.01% 454
2016
Q2 		$187K Buy
6,473
+261
+4% +$7.89K 0.01% 519
2016
Q1 		$218K Sell
6,212
-596
-9% -$19.2K 0.01% 448
2015
Q4 		$219K Buy
6,808
+239
+4% +$7.75K 0.01% 489
2015
Q3 		$212K Buy
6,569
+622
+10% +$23.4K 0.01% 495
2015
Q2 		$246K Sell
5,947
-7,263
-55% -$306K 0.01% 445
2015
Q1 		$594K Buy
13,210
+1,465
+12% +$61.2K 0.02% 368
2014
Q4 		$440K Buy
11,745
+669
+6% +$24.5K 0.02% 436
2014
Q3 		$387K Buy
11,076
+2,946
+36% +$105K 0.02% 422
2014
Q2 		$287K Sell
8,130
-4,770
-37% -$159K 0.01% 441
2014
Q1 		$421K Sell
12,900
-1,237
-9% -$47.3K 0.01% 486
2013
Q4 		$596K Buy
14,137
+8,317
+143% +$342K 0.02% 411
2013
Q3 		$232K Sell
5,820
-22
-0.4% -$923 0.01% 464
2013
Q2 		$242K Buy
+5,842
New +$237K 0.01% 448

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

PineBridge Investments's HAE Position: Q1 2025 in Review

PineBridge Investments sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 22,483 shares — an estimated $1.76M sold.

PineBridge Investments first reported a position in HAE in Q2 2013 and held it in 24 quarters. The position peaked at $3.02M in Q2 2018. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • PineBridge Investments reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
  • PineBridge Investments sold 22,483 Haemonetics shares in Q1 2025, an estimated $1.76M.
  • PineBridge Investments first reported a position in Haemonetics in Q2 2013 and held it in 24 quarters.
  • PineBridge Investments's Haemonetics position peaked at $3.02M in Q2 2018.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on PineBridge Investments's 13F filing for Q1 2025, filed 14 May 2025.